FDA Inspection 917301 — Bristol Myers Squibb Company
The FDA completed an inspection of Bristol Myers Squibb Company on Mar 10, 2015 in Plainsboro, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 10, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Plainsboro, NJ (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)